Abstract: P967 INFLUENCE OF METABOLIC SYNDROME (MS) FACTORS AND INSULIN RESISTANCE (IR) ON EZETIMIBE (E)/SIMVASTATIN (S) AND ATORVASTATIN (A) EFFICACY IN PATIENTS WITH MS AND MODERATELY HIGH (MH) OR HIGH (H) CHD RISK
Rosen, J, Ballantyne, C, Grundy, S, Hsueh, W, Parving, H, Robinson, J, Lin, J, Lowe, R, Shah, A, Tershakovec, AVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/S1567-5688(09)71088-8
Date:
June, 2009
File:
PDF, 271 KB
english, 2009